Creutzfeldt-Jakob disease spreads through several distinct routes depending on which form of the disease is involved, but not through casual contact, airborne droplets, or the kinds of everyday interactions that transmit most infectious diseases. The majority of CJD cases arise spontaneously with no identifiable external source, while a smaller fraction are inherited through mutations in the prion protein gene and an even smaller fraction result from medical procedures or, in the case of variant CJD, dietary exposure to prion-contaminated beef. Understanding these routes matters because the infectious agent behind CJD is not a virus or bacterium but a misfolded protein called a prion, which behaves unlike any conventional pathogen and resists standard sterilization.
What Makes Prions Different from Other Infectious Agents
The agent responsible for CJD is a misshapen version of a protein your brain cells already produce. The normal form, known as cellular prion protein, sits on the surface of neurons and is harmless. In CJD, this protein refolds into an abnormal shape that is rich in a structural pattern called beta-sheet, replacing the normal alpha-helix-rich structure. Once this misfolded form appears, it acts as a template, forcing neighboring normal proteins to adopt the same distorted shape in a chain reaction that accelerates over time.
This self-propagating misfolding leads to a buildup of insoluble protein clumps in the brain, which progressively destroys neurons and leaves the brain tissue riddled with tiny holes, giving it a sponge-like appearance under a microscope.1PubMed Central. Prion protein misfolding Because prions contain no DNA or RNA, they cannot be killed the way bacteria or viruses can. They are extraordinarily resistant to heat, radiation, and chemical disinfectants that would destroy any conventional germ, which is what makes their transmission routes so unusual and their decontamination so difficult.
Sporadic CJD and Why Most Cases Have No External Source
Roughly 85 to 90 percent of CJD cases are classified as sporadic, meaning they appear without any known exposure to an outside source of prions and without an inherited mutation. This is, by a wide margin, the most common form of the disease, and it is also the most mysterious. The prevailing hypothesis is that sporadic CJD begins when a single prion protein molecule in the brain spontaneously misfolds and then triggers the chain reaction described above. Why this happens in some people and not others remains unclear.
One line of research has investigated whether somatic mutations in the prion protein gene, acquired during a person’s lifetime rather than inherited, might explain sporadic cases. A 2023 study found elevated rates of a specific somatic mutation in the brain tissue of sporadic CJD patients compared to controls.2PubMed Central. Elevated E200K Somatic Mutation of the Prion Protein Gene (PRNP) in the Brain Tissues of Patients with Sporadic Creutzfeldt-Jakob Disease (CJD) However, a larger and more methodologically rigorous study using deep DNA sequencing of over 200 sporadic CJD cases and 170 controls failed to confirm this. That study concluded that clonal somatic mutations in the prion gene may not play a major role in sporadic prion disease.3PubMed Central. Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease So the honest answer is that we still do not know what initiates the misfolding event in most CJD patients. It is not, strictly speaking, “transmitted” at all in the usual sense of the word.
Genetic CJD and Inherited Mutations
About 10 to 15 percent of CJD patients carry a pathogenic mutation in the prion protein gene, PRNP, located on chromosome 20. These mutations are inherited in an autosomal dominant pattern, meaning a child of an affected parent has a roughly 50 percent chance of inheriting the mutation. However, penetrance varies, so not everyone who carries a mutation will develop the disease during their lifetime.4PubMed. Genetic Creutzfeldt-Jakob disease
The most common mutation associated with genetic CJD is called E200K. Research has shown that the prion strains isolated from patients with the E200K mutation correspond to the same strains found in sporadic CJD, which blurs the line between “genetic” and “sporadic” forms and suggests the mutation essentially lowers the threshold for the same misfolding process to begin.5PubMed Central. Characterization of prion strains and peripheral prion infectivity patterns in E200K genetic CJD patients Another mutation, T183A, has been shown in laboratory studies to dramatically increase the protein’s tendency to aggregate, to the point where amyloid formation can occur under normal physiological conditions.6PubMed Central. Mechanism of misfolding of the human prion protein revealed by a pathological mutation In genetic CJD, the “transmission” is vertical, from parent to child through DNA, rather than through any infectious exposure.
Iatrogenic Transmission Through Medical Procedures
Iatrogenic CJD refers to cases transmitted through medical or surgical procedures, and this is the route that has historically generated the most public health concern. The documented sources of iatrogenic transmission include contaminated neurosurgical instruments, depth electrodes used in brain recordings, cadaveric dura mater grafts, corneal transplants, and injections of human pituitary-derived growth hormone or gonadotrophin.7JAMA Neurology. Human Growth Hormone–Related Iatrogenic Creutzfeldt-Jakob Disease With Abnormal Imaging
The growth hormone cases are particularly striking because of their extraordinarily long incubation periods. Before synthetic growth hormone became available in 1985, children with growth disorders were treated with hormone extracted from the pituitary glands of human cadavers. Some of those cadavers harbored undiagnosed CJD, and the pooled hormone preparations carried prion contamination. A recent case report documented a patient who developed CJD a full 48 years after receiving cadaveric growth hormone, the longest incubation period recorded for this route.8PubMed Central. Cadaveric Human Growth Hormone-Associated Creutzfeldt-Jakob Disease with Long Latency Period, United States This case underscores something unsettling about prion diseases: the gap between exposure and symptoms can span decades.
Dura mater grafts, which were widely used in neurosurgery, accounted for a large number of iatrogenic cases. A review documented 71 cases linked to dural transplants, nearly all traced to a single commercial product that was recalled in 1996. A smaller number of cases, four in total, were linked to corneal grafts, at least two of which came from donors who had died of sporadic CJD.9Journal of the Neurological Sciences. Creutzfeldt–Jakob disease via dural and corneal transplants More recent research has confirmed that prion seeds can distribute throughout the eyes of sporadic CJD patients, reinforcing why corneal tissue poses a theoretical risk.10PubMed Central. Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients
Why Standard Sterilization Falls Short
One of the most practically important facts about prion transmission is that standard hospital sterilization and decontamination procedures may not fully eliminate prion infectivity from surgical instruments.11PubMed Central. Human prion diseases: surgical lessons learned from iatrogenic prion transmission The World Health Organization has recommended harsh chemical treatments such as prolonged exposure to sodium hydroxide or sodium hypochlorite, or autoclaving at unusually high temperatures. These methods work, but they can damage delicate surgical instruments, making them impractical for routine use on expensive reusable equipment.
This has spurred a search for milder but still effective decontamination options. A 2024 study developed a high-throughput screening method using prion-coated stainless steel beads to mimic contaminated instruments and tested roughly 70 commercially available formulations. Only a handful proved highly effective: one hypochlorite-based formula, two alkaline formulations, and one alkaline pre-cleaner stood out.12PubMed Central. Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic Separately, researchers identified a new formulation called TFD Premium that was shown to match or outperform the WHO reference methods against human prions while being compatible with both manual and automated reprocessing of medical devices.13PubMed. Optimization and evaluation of new decontamination procedures inactivating human prions These advances are important because the gap between knowing prions resist standard sterilization and having practical alternatives has been a real vulnerability in hospital infection control.
Variant CJD and the BSE Link
Variant CJD is a distinct form of the disease that emerged in the United Kingdom in the mid-1990s and was traced to dietary exposure to beef contaminated with bovine spongiform encephalopathy, commonly known as mad cow disease. Strain-typing experiments in mice provided strong evidence linking the BSE agent to the agent causing variant CJD.14PubMed Central. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease Unlike sporadic CJD, variant CJD tends to affect younger people, progresses more slowly, and shows a distinctive pattern of prion accumulation in the lymphoreticular system, meaning the spleen, lymph nodes, and tonsils, rather than being confined to the brain.15PubMed Central. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study
This peripheral tissue involvement is what makes variant CJD uniquely relevant to blood supply safety. Because the misfolded prion protein circulates in immune cells outside the brain, it can be present in donated blood from people who are incubating the disease but show no symptoms yet.
Blood Transfusion as a Transmission Route
To date, five patients are suspected to have acquired variant CJD or a vCJD infection after receiving blood products from donors who later developed the disease. All five received non-leukodepleted blood products in the United Kingdom between 1994 and 1999, before the adoption of universal leukodepletion, which removes white blood cells from donated blood.16Transfusion Medicine Reviews. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks The first suspected transfusion case involved a patient who developed symptoms about six and a half years after receiving red blood cells donated by someone who developed variant CJD three and a half years after the donation.17PubMed. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
These cases prompted blood services worldwide to adopt donor deferral policies that excluded people who had spent significant time in the UK or other countries affected by BSE during the outbreak years. These policies were effective at reducing theoretical risk but came at a cost: they excluded large numbers of otherwise eligible donors. In New Zealand, the policy excluded about 10 percent of active blood donors.18PubMed. Low risk of variant Creutzfeldt-Jakob disease transmission from blood transfusions in Aotearoa New Zealand suggests donor exclusion policies can be relaxed Modeling in the United States suggested that narrowing deferral to donors with extended exposure in just three high-risk countries, combined with leukoreduction of red cell units, could reduce vCJD risk by about 89 percent while recovering donations from an additional 100,000 currently deferred donors.19PubMed. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies Several countries, including Ireland and Australia, have already relaxed their deferral rules in recent years as the risk has declined with the passage of time since the BSE epidemic peaked.
What Does Not Transmit CJD
Given how frightening prion diseases sound, it is worth being explicit about what the evidence rules out. There is no evidence that CJD spreads through airborne routes, through touching or caring for a patient, or through contact with a patient’s secretions or excretions in daily occupational settings.20PubMed Central. Creutzfeldt-Jakob disease and infection control You cannot catch CJD by shaking hands with someone who has it, sharing a meal with them, or living in the same house. Healthcare workers who care for CJD patients using standard precautions are not at elevated risk. The disease is not transmitted sexually, and epidemiological studies have not found it to be more common in spouses of affected patients.
Vertical transmission from mother to child is another area that has been investigated. Sporadic CJD rarely affects women of childbearing age, but when it does, the question naturally arises. Testing of placental tissues using sensitive prion detection assays has not found evidence of infectivity in products of gestation.21PubMed Central. Creutzfeldt–Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues Additionally, follow-up on four children born to mothers with CJD found that none had developed the disease when they were checked at ages ranging from 3 to 22 years.22The American Journal of Pathology. Failure to Detect the Presence of Prions in the Uterine and Gestational Tissues from a Gravida with Creutzfeldt-Jakob Disease While these numbers are small, the absence of any documented case of mother-to-child transmission across all surveillance data is reassuring.
Genetic Susceptibility and Codon 129
Not everyone is equally susceptible to CJD if exposed. A common genetic variation at position 129 of the prion protein gene, where a person can carry either methionine or valine, has a strong influence on risk. This polymorphism is a recognized genetic marker for CJD susceptibility, and homozygosity at this position (carrying two copies of the same variant) appears to increase vulnerability compared to being heterozygous.23PubMed. Creutzfeldt-Jakob disease risk and PRNP codon 129 polymorphism: necessity to revalue current data All clinical cases of variant CJD tested to date have been homozygous for methionine at this position, which has raised questions about whether heterozygous individuals exposed to BSE might simply have much longer incubation periods rather than being truly resistant.
The Species Barrier and Chronic Wasting Disease
The BSE-to-human jump that produced variant CJD raised an obvious follow-up: could other animal prion diseases cross into humans? The most actively debated candidate is chronic wasting disease, a prion disease spreading through deer and elk populations across North America. Whether CWD prions can infect humans is currently unresolved.
Prion diseases generally do not jump easily between species. The compatibility between a prion and a new host depends on factors including the protein’s amino acid sequence, its three-dimensional structure, and its glycosylation patterns.24PubMed. Species barriers in prion diseases–brief review Analysis of the prion protein gene across mammals shows that deer, sheep, and cattle are relatively closely related on the evolutionary tree, while all three are fairly distant from humans. Since BSE managed to cross from cattle to people, sheer evolutionary distance alone cannot guarantee a species barrier between deer and humans. However, researchers have identified four specific amino acid differences in a critical loop region of the protein that might prevent CWD prions from converting the human form, potentially disrupting a structural feature needed for the misfolding chain reaction.25PubMed. Genetic and evolutionary considerations of the Chronic Wasting Disease – Human species barrier
Laboratory experiments in transgenic mice add another layer of complexity. When mouse and deer prion proteins are coexpressed, the deer protein can influence the selection of prion strains with expanded host range properties during the conversion of the mouse protein, suggesting that mixed-species environments could potentially favor strains that are more versatile in the hosts they can infect.26PubMed Central. Regulated coexpression of PrP from different species in mice impacts the replication and host range properties of prion strains No human case of CWD has been documented, but given incubation periods that can stretch beyond 50 years, public health agencies continue to advise against eating meat from CWD-positive animals.
Environmental Persistence and Indirect Exposure
One reason animal prion diseases are so difficult to control is that prions shed into the environment remain infectious for remarkably long periods. Prions bind strongly to soil particles and retain their infectivity, creating a persistent reservoir that can expose animals long after an infected individual has left or died.27PubMed Central. Prions in the environment: occurrence, fate and mitigation In aquatic environments, CWD prions associate primarily with fine sediments and can persist for at least a year.28PubMed Central. Prion Partitioning and Persistence in Environmental Waters In soils, infectivity can last for years, and the prion protein is both retained at the surface and transported downward through the soil column depending on the soil type and water chemistry.29PubMed. Prion Transport in Soils Varies with Soil and Porewater Properties
This environmental persistence is primarily relevant to animal prion diseases like CWD and scrapie in sheep rather than to human CJD directly. But it illustrates why prion diseases are so hard to eradicate once established in a wildlife population, and why the potential for a future species jump warrants monitoring. You cannot simply clean up a contaminated landscape the way you can disinfect a hospital ward.
How Diagnosis Has Improved and What That Means for Safety
Historically, a definitive CJD diagnosis required examining brain tissue after death. That delay created problems for infection control because patients could undergo neurosurgical procedures before their disease was suspected. A laboratory test called RT-QuIC, which stands for real-time quaking-induced conversion, has changed that picture. The test works by detecting prion seeding activity in cerebrospinal fluid and has achieved sensitivity above 90 percent with specificity approaching 100 percent in multiple large studies.30PubMed Central. RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease Improvements to the assay have boosted sensitivity further while cutting average detection time by about two days.31PubMed Central. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis
From a transmission standpoint, faster and more accurate diagnosis matters because it allows hospitals to flag suspected cases earlier, triggering appropriate instrument quarantine protocols and preventing the kind of iatrogenic exposures that occurred in past decades. The same RT-QuIC technology is also being adapted for screening tissues and decontamination validation, as in the surgical instrument study described above, making it a dual-use tool for both diagnosis and prevention.32PubMed Central. Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt-Jakob Disease in Denmark
Lessons from Kuru
Much of what we understand about human prion transmission comes from kuru, a prion disease that reached epidemic proportions among the Fore people of Papua New Guinea in the mid-twentieth century. Kuru was transmitted through a mortuary practice in which deceased relatives were consumed as part of funeral rites. Women and children, who participated most in these rituals and handled the most infectious tissues including brain, were disproportionately affected. When the practice was prohibited in the 1950s, new cases gradually declined, but the epidemic stretched into the 2000s because some individuals had incubation periods exceeding 50 years.33PubMed Central. The epidemiology of kuru: monitoring the epidemic from its peak to its end
Kuru demonstrated two facts that still shape our understanding of CJD transmission. First, oral ingestion of prion-contaminated tissue can cause disease in humans, which is the same route implicated in variant CJD from BSE-contaminated beef. Second, prion incubation periods in humans can be astonishingly long, measured not in months or even a few years but in decades. That second fact continues to complicate public health planning, because it means the full consequences of a prion exposure event may not become apparent for a generation.